RBF Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,000
Closed -$612K 447
2020
Q4
$612K Buy
+4,000
New +$612K 0.05% 255